• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

GLP-1 receptor agonists for the treatment of obstructive sleep apnea and obesity.

作者信息

Romariz Livia, Araújo Beatriz, Barbosa Lucas M, Jain Riddhi, Porto Silva Janovsky Carolina C

机构信息

Estácio de Sá University, Av. Pres. Vargas, 1111 - Centro, Rio de Janeiro - RJ, Br - 20071-004, RJ, Brazil.

Nove de Julho University, São Bernardo do Campo, SP, Brazil.

出版信息

Eur J Intern Med. 2025 Feb;132:153-155. doi: 10.1016/j.ejim.2024.10.027. Epub 2024 Nov 16.

DOI:10.1016/j.ejim.2024.10.027
PMID:39550278
Abstract
摘要

相似文献

1
GLP-1 receptor agonists for the treatment of obstructive sleep apnea and obesity.用于治疗阻塞性睡眠呼吸暂停和肥胖症的胰高血糖素样肽-1受体激动剂。
Eur J Intern Med. 2025 Feb;132:153-155. doi: 10.1016/j.ejim.2024.10.027. Epub 2024 Nov 16.
2
Current perspectives on the use of GLP-1 receptor agonists in obesity-related obstructive sleep apnea: a narrative review.胰高血糖素样肽-1受体激动剂在肥胖相关阻塞性睡眠呼吸暂停中的应用现状：一篇叙述性综述
Expert Opin Pharmacother. 2025 Jan;26(1):51-62. doi: 10.1080/14656566.2024.2437525. Epub 2024 Dec 6.
3
Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis.用于治疗阻塞性睡眠呼吸暂停的胰高血糖素样肽-1受体激动剂：一项荟萃分析。
Sleep. 2025 Apr 11;48(4). doi: 10.1093/sleep/zsae280.
4
Safety and efficacy of glucagon-like peptide-1 receptor agonists in patients with obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials.胰高血糖素样肽-1受体激动剂在阻塞性睡眠呼吸暂停患者中的安全性和有效性：一项随机对照试验的系统评价和荟萃分析
Eur Clin Respir J. 2025 Mar 24;12(1):2484048. doi: 10.1080/20018525.2025.2484048. eCollection 2025.
5
Estimating Cardiovascular Benefits of Tirzepatide in Sleep Apnea and Obesity: Insight from the SURMOUNT-OSA Trials.评估替尔泊肽在睡眠呼吸暂停和肥胖中的心血管获益：来自 SURMOUNT-OSA 试验的见解。
Curr Obes Rep. 2024 Dec;13(4):739-742. doi: 10.1007/s13679-024-00592-x. Epub 2024 Oct 8.
6
Glucagon-like Peptide-1 receptor agonists for obstructive sleep apnea in patients with obesity and type 2 diabetes mellitus: a systematic review and meta-analysis.胰高血糖素样肽-1受体激动剂用于肥胖和2型糖尿病患者阻塞性睡眠呼吸暂停：一项系统评价和荟萃分析。
J Transl Med. 2025 Apr 3;23(1):389. doi: 10.1186/s12967-025-06302-y.
7
Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial.特立帕肽治疗阻塞性睡眠呼吸暂停：SURMOUNT-OSA 三期临床试验的原理、设计和样本基线特征。
Contemp Clin Trials. 2024 Jun;141:107516. doi: 10.1016/j.cct.2024.107516. Epub 2024 Mar 26.
8
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.替尔泊肽治疗阻塞性睡眠呼吸暂停和肥胖。
N Engl J Med. 2024 Oct 3;391(13):1193-1205. doi: 10.1056/NEJMoa2404881. Epub 2024 Jun 21.
9
Efficacy and safety of GLP-1 receptor agonists in the management of obstructive sleep apnea in individuals without diabetes: A systematic review and meta-analysis of randomized, placebo-controlled trials.胰高血糖素样肽-1受体激动剂在非糖尿病个体阻塞性睡眠呼吸暂停管理中的疗效和安全性：一项随机、安慰剂对照试验的系统评价和荟萃分析。
Sleep Med. 2025 May;129:40-44. doi: 10.1016/j.sleep.2025.02.010. Epub 2025 Feb 13.
10
[SURMOUNT-OSA study : tirzepatide improves obstructive sleep apnoea in patients with obesity].[SURMOUNT-OSA研究：替尔泊肽改善肥胖患者的阻塞性睡眠呼吸暂停]
Rev Med Liege. 2025 Apr;80(4):251-257.

引用本文的文献

1
Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025).GLP-1疗法的新兴前沿：全面的证据基础（2025年）
Pharmaceutics. 2025 Aug 9;17(8):1036. doi: 10.3390/pharmaceutics17081036.
2
Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.司美格鲁肽：治疗心血管-肾脏-代谢综合征的关键药物。
Future Cardiol. 2025 Jul;21(9):663-683. doi: 10.1080/14796678.2025.2511412. Epub 2025 Jun 3.
3
GLP-1 receptor agonists efficacy in managing comorbidities associated with diabetes mellitus: a narrative review.
胰高血糖素样肽-1受体激动剂在治疗糖尿病相关合并症中的疗效：一项叙述性综述
J Diabetes Metab Disord. 2025 Apr 1;24(1):92. doi: 10.1007/s40200-025-01604-w. eCollection 2025 Jun.